Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8672323 | Journal of Vascular Surgery | 2017 | 9 Pages |
Abstract
This study is a continuation of our previous, innovative in vitro study, which analyzed the best endograft and one parallel-stent combination, but now analyzing the performance of two and three parallel stents. We have observed comparable results: 30% endograft oversizing is still probably the most optimal, and the Excluder-Viabahn combination is related to smaller gutters, but higher stent compression and risk of infolding, than with Endurant-BeGraft. Infolding was also greater with three than with two parallel stents. These novel in vitro results can be very useful in planning EVAR with several parallel-stent procedures, where there is a paucity of factual knowledge.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gaspar MD, PhD, FEBVS, Xavier MD, FEBVS, Ana MD, Rodrigo MD, Savino MD, Xavier MD, Vincent MD, PhD,